Fly News Breaks for February 27, 2015
ACAD
Feb 27, 2015 | 09:06 EDT
JMP Securities increased its price target on ACADIA based on its higher sales estimates for the company's anti-psychotic drug, NUPLAZID, after the company raised the price of the drug. The firm reiterates an Outperform rating on the shares.
News For ACAD From the Last 2 Days
There are no results for your query ACAD